Cellebrite Di Ltd.NASDAQ: CLBT

CLBT FY26 Q2 Historical Financial Tables and Supplemental Data

Aug 13, 2026 at 12:11 PM UTC · Issued by Cellebrite Di Ltd.

Watch Cellebrite Di explain itCellebrite DI Ltd. (CLBT) Q2 2026 Earnings Call · Replay · Aug 13

Investor Kit Second Quarter 2026

FY 2023

Yr Ended

31-Dec

$ 271,028

82,007

353,035

17,285

30,883

401,203

26,004

-16,200

20,389

62,593

338,610

98,415

132,389

50,900

281,704

56,906

(332,890)

(275,984)

7,023

$ (283,007)

$ (1.35)

209,471,827

84.4%

24.5%

33.0%

12.7%

70.2%

14.2%

-2.5%

-70.5%

FY 2024

Yr Ended

31-Dec

$ 330,765

96,245

427,010

17,771

30,894

475,675

37,461

15,617

22,007

75,172

400,503

113,877

154,814

65,332

334,023

66,480

24,198

90,678

12,352

$ 78,326

$ 0.32

$ 0.31

241,626,316

249,903,126

84.2%

23.9%

32.5%

13.7%

70.2%

14.0%

13.6%

16.5%

YTD

30-Jun

$ 194,234

43,109

237,343

7,580

14,516

259,439

30,219

-7,261

10,147

47,627

211,812

71,833

86,975

36,936

195,744

16,068

8,753

24,821

7,512

$ 17,309

$ 0.07

247,047,007

252,436,239

81.6%

27.7%

33.5%

14.2%

75.4%

6.2%

30.3%

6.7%

FY 2025 FY 2026

Cellebrite DI Ltd. Condensed and Consolidated - US GAAP Income Statements

(U.S. Dollars in thousands, except share and per share data - unaudited)

Quarter Ended 31-Mar 30-Jun 30-Sep 31-Dec Quarter Ended 31-Mar 30-Jun Revenue:

Subscription services

$ 76,688 $

80,814 $

84,195 $

89,068

$ 96,549

$ 97,685

Term-license Total subscription

Other non-recurring*

Professional services

Total revenue Cost of revenue: Subscription services Term-license

Other non-recurring* Professional services

Total cost of revenue

Gross profit

Operating expenses: Research and development Sales and marketing General and administrative Other Total operating expenses Operating income (loss) Financial income (expense), net Income (loss) before taxes on income

Tax expense (income)

19,141 22,147 28,531 26,426 95,829 102,961 112,726 115,494

4,411 3,292 5,504 4,564

7,309 7,023 7,799 8,763

107,549 113,276 126,029 128,821

8,432 8,522 10,005 10,502

- - - 87

3,301 3,198 4,791 4,327

5,757 5,957 5,518 4,775

17,490 17,677 20,314 19,691

90,059 95,599 105,715 109,130

27,277 28,611 28,124 29,865

38,768 38,685 38,800 38,561

11,746 13,886 19,801 19,899

- - - -

77,791 81,182 86,725 88,325 12,268 14,417 18,990 20,805

7,060 6,374 5,298 5,466

19,328 20,791 24,288 26,271

1,928 1,315 4,099 5,010

21,304 21,805

117,853 119,490

3,668 3,912

6,780 7,736

128,301 131,138

14,238 15,981

- -

3,497 3,764

4,685 5,462

22,420 25,207

105,881 105,931

35,872 35,961

43,222 43,753

17,668 19,268

- -

96,762 98,982 9,119 6,949

4,515 4,238

13,634 11,187

2,696 4,816

Net Income (loss)

Basic net earnings (loss) per share Diluted net earnings (loss) per share

Pro-forma weighted average number of shares used to compute basic net earnings per

$ 17,400

$ 0.07

$ 19,476 $

$ 0.08 $

20,189 $

0.08 $

21,261

0.09

0.08

$ 10,938

$ 0.04

$ 6,371

$ 0.03

$ 0.02

Yr Ended

31-Dec

$ 209,751

70,663

280,414

13,561

31,135

325,110

19,219

13,766

20,240

53,231

271,879

84,386

110,813

43,443

238,642

33,237

(108,800)

(75,563)

5,537

$ (81,100)

$ (0.42)

$ (0.43)

190,154,549

83.6%

26.0%

34.1%

13.4%

73.4%

10.2%

-7.3%

-24.9%

Pro-forma weighted average number of shares used to compute diluted net earnings per share

Gross margin

R&D % of total revenue S&M % of total revenue G&A % of total revenue

Total Operating Expenses % of total revenues

Operating margin Tax rate

Net margin

Note: This document should be read in conjunction with the Company's SEC Filings.

*Other non-recurring revenue is composed of hardware sales, usage fees and perpetual licenses, and

237,246,654 240,358,573 243,508,803 245,282,244

249,302,220 248,980,462 249,719,713 251,501,118

83.7% 84.4% 83.9% 84.7%

25.4% 25.3% 22.3% 23.2%

36.0% 34.2% 30.8% 29.9%

10.9% 12.3% 15.7% 15.4%

72.3% 71.7% 68.8% 68.6%

11.4% 12.7% 15.1% 16.2%

10.0% 6.3% 16.9% 19.1%

16.2% 17.2% 16.0% 16.5%

246,470,084 247,617,591

252,077,487 252,788,652

84.9% 80.8%

29.7% 27.4%

34.3% 33.4%

13.8% 14.7%

77.8% 75.5%

7.1% 5.3%

19.8% 43.0%

8.5% 4.9%

FY 2026

Quarter Ended Quarter Ended 31-Mar 30-Jun 30-Sep 31-Dec 31-Mar 30-Jun

76,688

80,814 $

84,195 $

89,068

96,549

97,685

19,141 22,147 28,531 26,426 21,304 21,805

95,829 102,961 112,726 115,494 117,853 119,490

4,411 3,292 5,504 4,564 3,668 3,912

7,309 7,023 7,799 8,763 6,780 7,736

107,549 113,276 126,029 128,821 128,301 131,138

8,113

-3,044

8,143

-2,943

9,361

-5,095

9,115

4,243

5,583 5,764 5,030 4,590

16,740 16,850 19,486 18,035

10,237

-3,423

4,456

18,116

10,092

-3,690

5,231

19,013

90,809

96,426

106,543

110,786

110,185

112,125

24,198

35,694

25,388

35,281

24,762

35,136

25,800

34,638

8,946 9,533 10,675 13,850

68,838 70,202 70,573 21,971 26,224 35,970

7,060 6,374 5,298

29,031 32,598 41,268

1,928 1,315 4,099

(924) (510) (309)

- - -

$ 26,179 $ 30,773 $ 36,860 $ 74,288 36,498

5,466

41,964

5,010

(260)

36,694

29,826

39,569

12,204

81,599 28,586

4,515

33,101

2,696

215

29,446

39,955

12,919

82,320 29,805

4,238

34,043

4,816

465

$ 30,620 $ 29,692

FY 2025

FY 2024

FY 2023

Yr Ended

31-Dec

$ 209,751

70,663

280,414

13,561

31,135

325,110

19,219

13,644

18,577

51,446

273,664

77,866

102,842

37,674

218,382

55,282

(108,800)

(53,518)

5,537

633

-119,348

$ 60,926

$ 0.31

$ 0.28

190,154,549

206,194,081

84.2%

24.0%

31.6%

11.6%

67.2%

17.0%

-9.2%

18.7%

Yr Ended

31-Dec

$ 271,028

82,007

353,035

17,285

30,883

401,203

26,004

-16,047

18,313

60,364

340,839

88,648

121,752

38,320

248,720

92,119

(332,890)

(240,771)

7,023

(4,049)

-349,604

$ 97,761

$ 0.45

$ 0.42

209,471,827

227,258,731

85.0%

22.1%

30.3%

9.6%

62.0%

23.0%

-1.2%

24.4%

Yr Ended

31-Dec

$ 330,765

96,245

427,010

17,771

30,894

475,675

34,732

15,325

20,967

71,111

404,564

100,148

140,749

43,004

283,901

120,663

24,198

144,861

12,352

(2,003)

$ 130,506

$ 0.54

$ 0.51

241,626,316

254,677,860

85.1%

21.1%

29.6%

9.0%

59.7%

25.4%

7.1%

27.4%

YTD

30-Jun

$ 194,234

43,109

237,343

7,580

14,516

259,439

20,329

-7,113

9,687

37,129

222,310

59,272

79,524

25,123

163,919

58,391

8,753

67,144

7,512

680

$ 60,312

$ 0.24

$ 0.23

247,047,007

259,390,445

85.7%

22.8%

30.7%

9.7%

63.2%

22.5%

12.2%

23.2%

Cellebrite DI Ltd. Condensed and Consolidated - Non-GAAP Income Statements

(U.S. Dollars in thousands, except share and per share data - unaudited)

Revenue:

Subscription services Term-license

Total subscription Other non-recurring* Professional services

Total revenue Cost of revenue: Subscription services Term-license

Other non-recurring* Professional services

Total cost of revenue

Gross profit

Operating expenses: Research and development Sales and marketing General and administrative Total operating expenses Non-GAAP operating income Financial Income, net Income (loss) before taxes on income

Tax expense (income) Income tax adjustment One time tax income Finance expense (income) Non-GAAP net income

Basic net earnings (loss) per share Diluted net earnings per share

Pro-forma weighted average number of shares used to compute basic net earnings per

$ 0.11 $

$ 0.10 $

0.13 $

0.12 $

0.15 $

0.14 $

0.15

0.14

$ 0.12

$ 0.11

Pro-forma weighted average number of shares used to compute diluted net earnings per share

Gross margin

R&D % of total revenue S&M % of total revenue G&A % of total revenue

Total Operating Expenses % of total revenues

Operating margin Tax rate

Net margin

Note: This document should be read in conjunction with the Company's SEC Filings.

*Other non-recurring revenue is composed of hardware sales, usage fees and perpetual licenses, and was previously referred to "Perpetual license and other." Changing the name for this type of revenue reflects that perpetual license revenue has declined to relatively insignificant levels with hardware sales now representing the majority of this type of revenue.

237,246,654 240,358,573 243,508,803 245,282,244

252,456,562 252,713,944 256,157,437 257,274,507

84.4% 85.1% 84.5% 86.0%

22.5% 22.4% 19.6% 20.0%

33.2% 31.1% 27.9% 26.9%

8.3% 8.4% 8.5% 10.8%

64.0% 62.0% 56.0% 57.7%

20.4% 23.2% 28.5% 28.3%

3.5% 2.5% 9.2% 11.3%

24.3% 27.2% 29.2% 28.5%

246,470,084 247,617,591

259,252,345 259,522,205

85.9% 85.5%

23.2% 22.5%

30.8% 30.5%

9.5% 9.9%

63.6% 62.8%

22.3% 22.7%

8.8% 15.5%

23.9% 22.6%

FY 2025 FY 2026

31-Mar Quarter Ended 30-Jun Quarter Ended 30-Sep 31-Mar 30-Jun

90,475

177,754

141,257

81,142

17,625

6,260

8,969

523,482

179,223

146,053

146,908

93,127

23,489

7,772

9,537

606,109

281,361

127,216

117,135

104,196

20,812

9,034

8,648

668,402

133,689

140,777

154,602

72,739

25,799

5,732

7,528

540,866

141,250

146,759

154,522

110,782

21,514

6,466

8,388

589,681

6,897

100,305

11,545

17,766

10,922

10,261

28,714

186,410

6,687

85,661

12,586

19,962

10,242

17,464

28,714

181,316

6,289

69,580

12,727

22,533

9,807

16,267

28,714

165,917

7,091

105,491

11,760

23,150

127,966

16,403

119,559

411,420

7,344

103,185

11,667

24,552

121,909

16,414

119,559

404,630 $ 709,892 $ 787,425 $ 834,319 $ 952,286 $ 994,311

10,214

53,932

219,442

4,210

287,798

10,587

67,969

227,177

4,236

309,969

11,136

62,486

239,677

3,618

316,917

10,868

79,652

255,095

4,596

350,211

18,113

77,009

263,350

5,736

364,208

6,566

45,641

-6,393

58,600

6,852

44,096

-18,095

69,043

7,510

44,386

-17,821

69,717

23,179

50,147

-18,209

91,535

24,573

49,940

-17,493

92,006 $ 346,398 $ 379,012 $ 386,634 $ 441,746 $ 456,214

* -510,153

(85)

890

(147,464)

363,494

* -533,847

(85)

2,639

(127,988)

408,413

* -553,111

(85)

2,459

(107,800)

447,685

* -585,233

(85)

992

(75,600)

510,540

* -605,809

(85)

1,602

(69,229)

538,097 $ 709,892 $ 787,425 $ 834,319 $ 952,286 $ 994,311

FY 2024

FY 2023

Yr Ended 31-Dec
$ 189,517 74,713 38,693 77,269 26,400 5,550 9,940
422,082
7,341 28,859 7,024 15,896 10,594 14,260 26,829
83,974
$ 506,056
$ 8,282 44,845 195,725 4,972
253,824
5,515 47,098 47,247 81,715 54,117 9,157
244,849
$ 498,673
* -(84,896) (85) 1,050 118,143
34,212
$ 532,885

Yr Ended 31-Dec
$ 191,659 153,746 101,818 82,358 23,246 5,827 8,939
567,593
7,682 36,601 11,072 16,995 11,306 10,604 28,714
122,974
$ 690,567
$ 11,077 63,330 216,970 4,125
295,502
6,954 45,247 - - -6,844
59,045
$ 354,547
* -498,883 (85) 2,086 (164,864)
336,020
$ 690,567

Yr Ended 31-Dec
$ 124,457 161,049 151,544 104,972 19,630 6,595 7,603
575,850
14,618 97,959 10,880 22,209 81,469 16,308 119,559
363,002
$ 938,852
$ 16,834 71,244 277,583 3,996
369,657
16,677 49,526 - - -18,674
84,877
$ 454,534
* -568,721 (85) 2,220 (86,538)
484,318
938,852

Cellebrite DI Ltd. Condensed and Consolidated - Balance Sheets

(U.S. Dollars in thousands)

ASSETS Current Assets

Cash and cash equivalents Short-term deposits Marketable securities Trade receivables

Prepaid expenses and other current assets Contract acquisition costs

Inventories

Total current assets Non-current assets Other non-current assets Marketable securities Deferred tax assets, net

Property and equipment, net Intangible assets, net

Operating lease right-of-use assets, net Goodwill

Total non-current assets

Total Assets

Liabilities, redeemable convertible preferred shares and shareholders' equity (deficiency) Current Liabilities

Trade payables

Other accounts payable and accrued expenses Deferred revenues

Operating lease liabilities

Total current liabilities Long-term Liabilities

Other long-term liabilities Long-term deferred revenues

Restricted Sponsor Shares liability Price Adjustment Shares liability Derivative warrant liabilities Operating lease liabilities

Total long-term liabilities Total Liabilities Shareholders' equity (deficiency)

Share capital

Additional paid-in capital

Treasury stock, NIS 0.00001 par value; 41,776 ordinary shares Accumulated other comprehensive income

(Accumulated deficit) Retained earnings Total shareholders' equity (deficiency)

Total liabilities, redeemable convertible preferred shares and shareholders' equity (deficiency)

* Less than US$ 1.

Note: This document should be read in conjunction with the Company's SEC Filings.

Yr Ended 31-Dec
$ (81,100) 18,998 (1,106) 10,011 -(7,737) 5,125 34,102 29,715 55,531 2,271 46,114 (5,610) (9,211) 4,362 (4,196) -243 3,691 734 121
102,058
(5,231) (2,687) (55,317) 56,336 - -(15,641)
(22,540)
-19,142 2,623
21,765
101,283 589 87,645
$189,517
$ 10,047 $ - $ - $ 4,363 $ - $ - $ -

Cellebrite DI Ltd. Condensed and Consolidated - Quarterly US GAAP Cash Flows

(U.S. Dollars in thousands - unaudited)

FY 2023 FY 2024

FY 2025

Yr Ended 31-Dec
$(283,007) 30,575 (2,904) 10,607 -(10,736) (4,015) 110,664 65,889 173,051 (5,829) 22,317 (341) 3,201 5,335 (4,839) -982 2,755 17,586 880
132,171
(8,566) (2,043) (127,789) 59,971 -(2,748) (68,298)
(149,473)
42 17,265 3,344
20,651
3,349 (1,207) 189,517
$ 191,659
$ 7,706 $ - $ - $ 1,884 $ 164,770 $ 113,136 $ 254,766

Yr Ended 31-Dec
$ 78,326 44,892 (2,371) 11,867 554 (8,164) 75 - - -(15,781) 49,768 (6,936) 5,614 4,585 547 1,760 1,632 4,943 4,248 (2,015)
173,544
(13,225) -(321,231) 152,992 59,809 (147,456) 861
(268,250)
-20,097 4,956
25,053
(69,653) 2,451 191,659
$124,457
$ (549) $ - $ - $ 11,154 $ - $ - $ -

Quarter Ended 31-Mar 30-Jun 30-Sep 31-Dec

FY 2026

YTD

30-Jun

$ 17,309

29,633

(1,385)

15,920

-(3,529)

(765)

-(5,629)

(12,874)

299

(613)

2,113

(1,660)

-(715)

1,194

(3,495)

1,671

37,474

(6,109)

(15,619)

(124,625)

60,945

55,546

(15,278)

17,819

(27,321)

-4,251

2,868

7,119

17,272

(479)

124,457

$141,250

$ 10,535

$ -

$ 2,219

$ -

Quarter Ended 31-Mar 30-Jun

Cash flows from operating activities:

Net income (loss)

Adjustments to reconcile net income to net cash provided by (used in) operating activities:

$ 17,400 $ 19,476 $ 20,189 $ 21,261 $ 10,938 $ 6,371

Share-based compensation and RSU's

Amortization of premium and discount and accrued interest on marketable securities Depreciation and amortization

Disposal and write-off of property and equipment Interest income from short-term deposits Deferred tax assets, net

Revaluation of derivative warrants

Remeasurement of Restricted Sponsor Shares liability Remeasurement of Price Adjustment Shares liability (Increase) decrease in trade receivables

Increase (decrease) in deferred revenue Decrease (increase) in other non-current assets

Decrease (Increase) in prepaid expenses and other current assets Changes in operating lease assets

Changes in operating lease liability

Abandonment of right-of-use assets and disposal of leasehold Improvements (Increase) decrease in inventories

(Decrease) increase in trade payables

Increase (decrease) in other accounts payable and accrued expenses (Decrease) increase in other long-term liabilities

Net cash provided by (used in) operating activities

Cash flows from investing activities:

Capital expenditures Purchase of intangible assets

Investment in marketable securities

Proceeds from maturities of marketable securities Proceeds from sales of marketable securities

Payment related to business combination, net of cash acquired

Short-term deposits, net

Net cash (used in) provided by investing activities

Cash flows from financing activities:

Exercise of warrants, net Exercise of options to shares Proceeds from ESPP, net

Net cash provided by financing activities Net (decrease) increase in cash and cash equivalents and restricted cash

Net effect of currency translation on cash and cash equivalents

Cash and cash equivalents and restricted cash at beginning of period

8,777 8,810 15,308 11,997

(523) (1,202) (488) (158)

2,631 2,592 2,703 3,941

- - - 554 (2,380) (2,303) (1,734) (1,747)

(386) (1,387) (51) 1,899

- - - -

- - - -1,721 (10,931) (11,225) 4,654

992 2,310 13,310 33,156

785 210 398 (8,329)

5,480 (2,748) 336 2,546

1,156 1,070 1,197 1,162

(1,179) (532) (892) 3,150

- - - 1,760

(10) (524) 882 1,284

(1,046) (166) 713 5,442

(12,152) 17,622 (8,032) 6,810

(388) 286 658 (2,571)

20,878 32,583 33,272 86,811

(2,339) (3,608) (3,322) (3,956)

- - - -(129,956) (53,190) (12,057) (126,028)

27,419 32,204 58,597 34,772

- 31,166 - 28,643

- - - (147,456) (21,628) 34,005 20,570 (32,086)

(126,504) 40,577 63,788 (246,111)

- - - -2,493 12,624 3,958 1,022

1,127 1,202 1,309 1,318

3,620 13,826 5,267 2,340 (102,006) 86,986 102,327 (156,960)

822 1,762 (189) 56

191,659 90,475 179,223 281,361

14,384 15,249

(1,148) (237)

7,005 8,915

- -

(1,793) (1,736)

(750) (15)

- -

32,441 (38,070)

(20,861) 7,987

552 (253)

(4,964) 4,351

1,055 1,058

(1,015) (645)

- -

144 (859)

(5,987) 7,181

(10,393) 6,898

277 1,394

19,885 17,589

(3,041) (3,068)

(7,059) (8,560)

(74,575) (50,050)

24,607 36,338

39,706 15,840

(15,278) 0

22,065 (4,246)

(13,575) (13,746)

- -

2,128 2,123

1,383 1,485

3,511 3,608 9,821 7,451

(589) 110

124,457 133,689

Cash and cash equivalents and restricted cash at end of period $ 90,475 $179,223 $281,361 $124,457 $133,689 $141,250 Supplemental cash flow information:

Income taxes (received) paid

$ 806

$ (8,879)

$ 4,686

$ 2,838

$ 3,538

$ -

$ 6,997

Purchase of property and equipment on suppliers' credit Purchase of intangible assets

$ - $ -

Operating lease liabilities arising from obtaining right of use assets

$ 813

$ 12,328 $ -

$ (1,987)

$ 1,150

$ 1,069

Reclassification of warrants from liability to equity

Reclassification of Restricted Sponsor Shares from liability to equity Reclassification of Price Adjustment Shares from liability to equity

Note: This document should be read in conjunction with the Company's SEC Filings.

$ - $ -

FY 2026

Quarter Ended Quarter Ended 31-Mar 30-Jun 30-Sep 31-Dec 31-Mar 30-Jun

$ 17,490 $ 17,677 $

20,314 $ 19,691

22,420

25,207

750 827

- -

$ 16,740 $ 16,850 $

828 775

- 881

- -

19,486 $ 18,035 $

692

3,612

18,116 $

657

5,536

19,013

$ 90,059 $ 95,599 $ 105,715

750 827 828

- - -

90,809 96,426 106,543

$ 109,130

775

881

$ 110,786

$ $ $ $

105,881

692

3,612

110,185

105,931

657

5,536

$ 112,125

$ 77,791 $ 81,182 $

86,725 $ 88,325

96,762

98,982

- -

8,027 7,983

926 931

- 2,066

- -

$ 68,838 $ 70,202 $

574 -

- -

14,480 11,222

934 1,227

164 1,588

- -

70,573 $ 74,288 $

-13,692

1,362

109

81,599 $

-14,592

1,394

676

82,320

FY 2025

FY 2024

FY 2023

Yr Ended

31-Dec

$ 53,231

1,733

$ 51,446

$ 271,879

1,733

$ 273,664

$ 238,642

-(345)

-17,265

3,347

(7)

$ 218,382

Yr Ended

31-Dec

$ 62,593

2,227

$ 60,364

$ 338,610

2,227

$ 340,839

$ 281,704

1,068

-28,348

3,349

219

$ 248,720

Yr Ended

31-Dec

$ 75,172

3,180

881

$ 71,111

$ 400,503

3,180

881

$ 404,564

$ 334,023

574

-41,712

4,018

3,818

$ 283,901

YTD

30-Jun

$ 47,627

1,349

9,148

$ 37,129

$ 211,812

1,349

9,148

$ 222,310

$ 195,744

-28,284

2,756

785

$ 163,919

GAAP to Non-GAAP Reconciliations

(U.S. Dollars in thousands, except share and per share data)

GAAP cost of revenue: Cost of revenue Less:

Share-based compensation expense Amortization of intangible assets Acquisition-related costs

Non-GAAP cost of revenue GAAP gross profit:

Gross profit

Share-based compensation expense Amortization of intangible assets Acquisition-related costs

Non-GAAP gross profit GAAP operating expenses: Operating expenses Less:

Executive severance costs Issuance expenses

Dividend participation compensation Share-based compensation expense Amortization of intangible assets Acquisition-related costs

Capital loss from FA disposal

Non-GAAP operating expenses

FY 2026

Quarter Ended Quarter Ended 31-Mar 30-Jun 30-Sep 31-Dec 31-Mar 30-Jun

12,268

-8,777

926

21,971

14,417

-8,810

931

2,066

26,224

18,990

574

-15,308

934

164

35,970

20,805

-11,997

2,108

1,588

36,498

9,119

-14,384

4,974

109

28,586

6,949

-15,249

6,930

677

29,805

17,400

-8,777

926

-(924)

26,179

19,476

-8,810

931

2,066

(510)

30,773

20,189

574

-15,308

934

164

(309)

36,860

21,261

-11,997

2,108

1,588

(260)

36,694

10,938

-14,384

4,974

109

215

30,620

6,371

-15,249

6,930

677

465

29,692

17,400

(7,060)

1,928

2,631

-8,777

23,676

22.0%

19,476

(6,374)

1,315

2,592

-8,810

2,066

27,885

24.6%

20,189

(5,298)

4,099

2,703

574

-15,308

164

37,739

29.9%

21,261

(5,466)

5,010

3,941

-11,997

1,588

38,331

29.8%

10,938

(4,515)

2,696

7,005

-14,384

109

30,617

23.9%

6,371

(4,238)

4,816

8,915

-15,249

677

31,790

24.2%

20,878 32,583 33,272 86,811 19,885 17,589

(2,339) (3,608)

$ 18,539 $ 28,975 $

(3,322) (3,956)

29,950 $ 82,855 $

(3,041)

16,844 $

(3,068)

14,521

FY 2025

FY 2024

FY 2023

Yr Ended 31-Dec
$ 33,237 -(345) -18,998 3,347 45
$ 55,282
$ (81,100) - -(345) -18,998 3,347 45 633 119,348
$ 60,926
$ (81,100) 108,800 5,537 10,011 -(345) -18,998 45
$ 61,946
19.1% 102,058 (5,231)
$ 96,827
29.8%

Yr Ended 31-Dec
$ 56,906 1,068 - -30,575 3,349 221
$ 92,119
$ (283,007) 1,068 - - -30,575 3,349 221 (4,049) 349,604
$ 97,761
$ (283,007) 332,890 7,023 10,607 1,068 - -30,575 221
$ 99,377
24.8% 132,171 (8,566)
$ 123,605
30.8%

Yr Ended 31-Dec
$ 66,480 574 - -44,892 4,899 3,818
$ 120,663
$ 78,326 574 - - -44,892 4,899 3,818 (2,003) -
$ 130,506
$ 78,326 (24,198) 12,352 11,867 574 - -44,892 3,818
$ 127,631
26.8% 173,544 (13,225)
$ 160,319
33.7%

YTD 30-Jun
$ 16,068 - - -29,633 11,904 786
$ 58,391
$ 17,309 - - - -29,633 11,904 786 680 -
$ 60,312
$ 17,309 (8,753) 7,512 15,920 - - -29,633 786
$ 62,407
24.1% 37,474 (6,109)
$ 31,365
12.1%

GAAP to Non-GAAP Reconciliations

(U.S. Dollars in thousands, except share and per share data)

GAAP operating income (loss) Executive severance costs Issuance expenses

Dividend participation compensation Share-based compensation expense Amortization of intangible assets Acquisition-related costs

Non-GAAP operating income (loss) GAAP net income (loss) Executive severance costs One-time tax income Issuance expenses

Dividend participation compensation Share-based compensation expense Amortization of intangible assets Acquisition related costs

Income tax expense Finance expenses (income)

Non-GAAP net income (loss) GAAP net income (loss) Financial (Income) expense Tax expense (income) Depreciation and amortization Executive severance costs Issuance expenses

Dividend participation compensation Share-based compensation expense Acquisition-related costs

Adjusted EBITDA

Adjusted EBITDA margin

Cash flows from operating activities

Less:

Capital expenditures

Free Cash Flow

Free Cash Flow margin

Note: This document should be read in conjunction with the Company's SEC Filings.

17.2% 25.6% 23.8% 64.3%

13.1% 11.1%

FY 2025

FY 2024

FY 2023

Yr Ended

31-Dec

$ 172,154

112,247

40,709

$ 325,110

53.0%

34.5%

12.5%

100.0%

315,689

165,389

114,206

36,094

125%

Yr Ended

31-Dec

$215,531 134,921

50,751

$ 401,203

53.7%

33.6%

12.6%

100.0%

395,899

-395,899

395,899

214,565

134,061

47,273

124%

Yr Ended

31-Dec

$256,582 161,361

57,732

$ 475,675

53.9%

33.9%

12.0%

100.0%

480,760

16,078

464,682

480,760

256,380

166,440

57,940

116%

FY 2026

Cellebrite DI Ltd. - Revenue Mix

(U.S. Dollars in thousands - unaudited)

Quarter Ended 31-Mar 30-Jun 30-Sep 31-Dec Quarter Ended

YTD

30-Jun

$ 135,255

90,125

34,059

$ 259,439

52.1%

34.7%

13.1%

100.0%

507,771

-507,771

507,771

267,414

175,072

65,285

117%

31-Mar 30-Jun Revenue by geography:

Americas

$ 56,531

$ 61,246

$ 72,805

$ 66,000

$ 66,006

$ 69,249

EMEA APAC

37,421 38,461 38,488 46,991

13,597 13,569 14,736 15,830

46,825 43,300

15,470 18,589

Total revenue

$ 107,549 $ 113,276 $ 126,029 $ 128,821 $ 128,301 $ 131,138 Revenue % of total:

Americas EMEA APAC

Total revenue

Annual recurring revenue (in thousands)

Total ARR

ARR related to acquisitions Organic ARR

Annual recurring revenue (in thousands)

America EMEA APAC

Recurring revenue net dollar-based retention rate

Note: This document should be read in conjunction with the Company's SEC Filings.

52.6% 54.0% 57.8% 51.2%

34.8% 34.0% 30.5% 36.5%

12.6% 12.0% 11.7% 12.3%

100.0% 100.0% 100.0% 100.0%

408,060 418,875 439,803 480,760

- - - 16,078 408,060 418,875 439,803 464,682 408,060 418,875 439,803 480,760

221,259 226,296 240,244 256,380

136,432 141,762 147,200 166,440

50,369 50,817 52,359 57,940

121% 120% 117% 116%

51.4% 52.8%

36.5% 33.0%

12.1% 14.2%

100.0% 100.0%

492,970 507,771

- -

492,970 507,771

492,970 507,771

261,090 267,414

170,930 175,072

60,950 65,285

115% 117%